Emanuelle Ferraz Baptista

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Centro de Ciências da Saúde

Unidade:

Faculdade de Medicina

Departamento:

Departamento de Radiologia/FM

ORCID:

não disponível no Lattes


Formação:

  • Universidade Federal do Rio de Janeiro

    Ciências Biológicas (Fisiologia) | Doutorado | 2014 - 2018

  • Universidade Federal do Rio de Janeiro

    Ciências Biológicas (Fisiologia) | Mestrado | 2011 - 2013

  • Centro Universitário Augusto Motta

    Fisioterapia em UTI | Especialização | 2008 - 2009

  • Centro Universitário Augusto Motta

    Fisioterapia | Graduação | 2004 - 2008
Laboratórios:
Nenhum laboratório cadastrado
Nuvens de Palavras:
Artigos:

(100.00% artigos com DOI)

Titulo DOI Ano
BKCa Channel Activation Attenuates the Pathophysiological Progression of Monocrotaline-Induced Pulmonary Arterial Hypertension in Wistar Rats 10.1007/s10557-020-07115-5 2020
Effects of high intensity interval training on neuro-cardiovascular dynamic changes and mitochondrial dysfunction induced by high-fat diet in rats 10.1371/journal.pone.0240060 2020
Effects of high intensity interval training on neuro-cardiovascular dynamic changes and mitochondrial dysfunction induced by high-fat diet in rats 10.1371/journal.pone.0240060 2020
Adenosine A2A  receptor agonist prevents cardiac remodeling and dysfunction in spontaneously hypertensive male rats after myocardial infarction 10.2147/dddt.s113289 2017
AT1 and Aldosterone Receptors Blockade Prevents the Chronic Effect of Nandrolone on the Exercise-Induced Cardioprotection in Perfused rat Heart Subjected to Ischemia and Reperfusion 10.1007/s10557-013-6503-8 2014
N-acylhydrazone derivative ameliorates monocrotaline-induced pulmonary hypertension through the modulation of adenosine AA2R activity 10.1016/j.ijcard.2014.02.022 2014
A novel Ca²+ channel antagonist reverses cardiac hypertrophy and pulmonary arteriolar remodeling in experimental pulmonary hypertension 10.1016/j.ejphar.2013.01.050 2013
Beneficial effects of a novel agonist of the adenosine A 2A receptor on monocrotaline-induced pulmonary hypertension in rats 10.1111/bph.12193 2013
The blockade of angiotensin AT 1 and aldosterone receptors protects rats from synthetic androgen-induced cardiac autonomic dysfunction 10.1111/apha.12056 2012
Eventos:

(0.00% eventos com DOI)

Titulo DOI Ano
EVALUATION OF CARDIOPROTECTIVE ACTIVITY 2017
INFLUENCE OF THYROID HORMONE ON PULMONARY ARTERIAL HYPERTENSION DEVELOPMENT 2017
PREVENTION OF METHYLMERCURY CARDIOVASCULAR TOXICITY BY GLIBENCLAMIDE AND ANTIOXIDANTS 2017
THE CARDIOPROTECTION BY 5-10 KDA HUMORAL FACTORS FROM ISCHEMIC PRECONDITIONING IS SENSITIVE TO INHIBITION OF PKC, KATP AND SAFE PATHWAYS. 2017
POTENCIAL TERAPÊUTICO DE CÉLULAS-TRONCO EM ASSOCIAÇÃO COM O INIBIDOR DE FOSFODIESTERASE-5 NA HIPERTENSÃO ARTERIAL PULMONAR INDUZIDA POR MONOCROTALINA EM RATOS 2016
Novel Multi-target Compound, Agonist of Adenosine receptor and inhibitor of phosphodiesterase 5 ameliorates monocrotaline induced-pulmonary hypertension in rats 2015
Novel A2A receptor agonist ameliorates ventricular and vascular dysfunction in monocrotaline-induced pulmonary arterial hypertension in rats 2013
N-ACHYLHYDRAZONE DERIVATIVE RECOVERED VASCULAR AND VASCULAR REMODELING IN MONOCROTALINE-INJECTED RATS 2013
New agonist of A2A receptor reduces ventricular and vascular dysfunction in monocrotaline-induced pulmonary arterial hypertension in rat 2012
THERAPEUTIC POTENTIAL OF AMD3100 IN PULMONARY ARTERIAL HYPERTENSION INDUCED BY MONOCROTALINE IN RATS 2011
THERAPEUTIC POTENTIAL OF AMD3100 IN PULMONARY ARTERIAL HYPERTENSION INDUCED BY MONOCROTALINE IN RATS 2011
Exercise Modulates The Inflammatory Process Reducing The Risk Of And Distal Organ Injury In Experimental 2010
Participação Do Sitema Renina-Angiotensina-Aldosterona Nos Efeitos Deletérios Do Decanoato De Nandrolona Na Cardioproteção Induzida Pelo Exercício Físico 2009
Chronic Treatment With Supraphysiological Doses Of Anabolic Steroids Modulates Cardiac Action Potencial 2009
Publicações:
Minha Rede: